- Departments, Labs and Institutes
- Research Centers and Programs
- Interventional Cancer Prevention Program
The overarching goal of the Interventional Cancer Prevention (ICP) program is to develop cancer prevention interventions and improve health in individuals at risk of cancer, cancer patients and survivors and to improve outcomes among populations with limited access to care.
The overarching goal of the Interventional Cancer Prevention (ICP) program is to develop cancer prevention interventions and improve health in individuals at risk of cancer, cancer patients and survivors and to improve outcomes among populations with limited access to care.
The three aims of the ICP program
The ICP program was developed to enhance collaboration between wet lab-based investigators, interventional behavioral scientists and cancer prevention investigators, as many effective cancer prevention interventions require combined behavioral, medical and inoculation-based interventions.
Aim 1
Interventions Targeting Cancer Initiation Pathways
Discover biological pathways critical for pre-cancer and cancer initiation and develop targeted interventions against these pathways using ex vivo and in vivo models
Aim 2
Interventions for At-risk Individuals
Develop, test and deliver preventative, interceptive and symptom-control interventions in individuals to mitigate cancer risk and progression, and improve survivor’s outcomes
Aim 3
Interventions for Communities & Populations
Develop, test, implement and disseminate innovative interventions to improve cancer-related health outcomes among populations with limited access to care
Leadership
Kathrin Milbury, Ph.D.
ICP Co-leader
Qian Lu, M.D., Ph.D.
ICP Co-leader
Eduardo Vilar-Sanchez, M.D., Ph.D.
ICP Associate Leader
Robert Volk, Ph.D.
ICP Cancer Research Training and Education Coordination Liaison
Scherazade Mama, Dr.P.H.
ICP Community Outreach and Engagement Liaison
ICP members regularly participate in the following activities
-
CCSG Prevention and Population Sciences Programs Retreat (CRO & ICP)
-
Cancer Prevention and Control Grand Rounds
More about the grand rounds
-
Behavioral Science Research News Hour
-
Cancer Prevention Center Quality Improvement (QI) and Education Series
Featured Publications
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial
JAMA, 2024
Cinciripini PM, Green CE, Shete S, Minnix JA, Robinson JD, Cui Y, Kim S, Kypriotakis G, Beneventi D, Blalock JA, Versace F, Karam-Hage M.
Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention
Gastroenterology, 2024
Bolivar AM, Duzagac F, Deng N, Reyes-Uribe L, Chang K, Wu W, Bowen CM, Taggart MW, Thirumurthi S, Lynch PM, You YN, Rodriguez-Pascual J, Lipkin SM, Kopetz S, Scheet P, Lizee GA, Reuben A, Sinha KM, Vilar E.
Expanding Active Living After Cancer To Underserved Cancer Survivors And Their Caregivers
Journal of the National Cancer Institute, 2024
Mama SK, Mitchell SJ, Tracy PV, Pena LY, Moreno CD, Valdes A, Liao Y, Lee CY, Alexander A, Raber MR, McNeill LH, Basen-Engquist K.
CCSG Research Programs
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.